THE BUSINESS OF BIOTECH
Physician + Biotech Builder with Tome Biosciences' Rahul Kakkar, M.D.
Novel technologies aren’t interesting to Rahul Kakkar, M.D. unless they help patients. Sounds rational, but it’s actually a unique perspective in a platform-crazed biotech industry. Dr. Kakkar’s worldview is shaped by his work as a physician—work he continues at Brigham and Women’s Hospital even as he builds Tome Biosciences, where he serves as President & CEO.
ABOUT THE BUSINESS OF BIOTECH
Created exclusively for the leaders of new and emerging biopharma firms, The Business of Biotech tackles organizational, funding, HR, regulatory, production and CMC considerations with insight from peer founders who have taken biologic therapies from an idea to clinical success.
FEATURED GUESTS
Rahul Kakkar
Bobby Reddy
Jason Gardner
Karen Harris
Michael Nally
Gavin Samuels
Robert Williamson
Brian Finrow
Jack Hoppin
Guillaume Pfefer
MEET THE HOST
Hosted by Bioprocess Online Chief Editor Matt Pillar, The Business of Biotech brings you weekly intelligence and insight, from leading voices in the biotech industry.
Interested in joining us on air ? Contact us
RECENT EPISODES
FINANCE & CAPITAL MARKETS
Building A Biotech Hub With Intellia Therapeutics' John Leonard, M.D.
DISCOVERY
REGULATORY
MANUFACTURING
CDMO With A Pipeline Featuring Forge Biologics President & CEO Dr. Timothy J. Miller
Product Vs. Platform With Surface's Vito Palombella, Ph.D. And Robert Ross, M.D.
Inflammation & Antibodies With Ampio Pharmaceutical's Mike Martino, CEO
Managing Momentum With Rezolute Bio's Nevan Charles Elam, JD
Cell Therapy Platform Dev With Precigen CEO Dr. Helen Sabzevari
